TY - JOUR
T1 - Systematic Design of Adenosine Analogs as Inhibitors of a Clostridioides difficile-Specific DNA Adenine Methyltransferase Required for Normal Sporulation and Persistence
AU - Zhou, Jujun
AU - Horton, John R.
AU - Menna, Martina
AU - Fiorentino, Francesco
AU - Ren, Ren
AU - Yu, Dan
AU - Hajian, Taraneh
AU - Vedadi, Masoud
AU - Mazzoccanti, Giulia
AU - Ciogli, Alessia
AU - Weinhold, Elmar
AU - Hüben, Michael
AU - Blumenthal, Robert M.
AU - Zhang, Xing
AU - Mai, Antonello
AU - Rotili, Dante
AU - Cheng, Xiaodong
N1 - Publisher Copyright:
© 2023 American Chemical Society. All rights reserved.
PY - 2023/1/12
Y1 - 2023/1/12
N2 - Antivirulence agents targeting endospore-transmitted Clostridioides difficile infections are urgently needed. C. difficile-specific DNA adenine methyltransferase (CamA) is required for efficient sporulation and affects persistence in the colon. The active site of CamA is conserved and closely resembles those of hundreds of related S-adenosyl-l-methionine (SAM)-dependent methyltransferases, which makes the design of selective inhibitors more challenging. We explored the solvent-exposed edge of the SAM adenosine moiety and systematically designed 42 analogs of adenosine carrying substituents at the C6-amino group (N6) of adenosine. We compare the inhibitory properties and binding affinity of these diverse compounds and present the crystal structures of CamA in complex with 14 of them in the presence of substrate DNA. The most potent of these inhibitors, compound 39 (IC50∼0.4 μM and KD∼0.2 μM), is selective for CamA against closely related bacterial and mammalian DNA and RNA adenine methyltransferases, protein lysine and arginine methyltransferases, and human adenosine receptors.
AB - Antivirulence agents targeting endospore-transmitted Clostridioides difficile infections are urgently needed. C. difficile-specific DNA adenine methyltransferase (CamA) is required for efficient sporulation and affects persistence in the colon. The active site of CamA is conserved and closely resembles those of hundreds of related S-adenosyl-l-methionine (SAM)-dependent methyltransferases, which makes the design of selective inhibitors more challenging. We explored the solvent-exposed edge of the SAM adenosine moiety and systematically designed 42 analogs of adenosine carrying substituents at the C6-amino group (N6) of adenosine. We compare the inhibitory properties and binding affinity of these diverse compounds and present the crystal structures of CamA in complex with 14 of them in the presence of substrate DNA. The most potent of these inhibitors, compound 39 (IC50∼0.4 μM and KD∼0.2 μM), is selective for CamA against closely related bacterial and mammalian DNA and RNA adenine methyltransferases, protein lysine and arginine methyltransferases, and human adenosine receptors.
UR - http://www.scopus.com/inward/record.url?scp=85145455635&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85145455635&partnerID=8YFLogxK
U2 - 10.1021/acs.jmedchem.2c01789
DO - 10.1021/acs.jmedchem.2c01789
M3 - Article
C2 - 36581322
AN - SCOPUS:85145455635
SN - 0022-2623
VL - 66
SP - 934
EP - 950
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 1
ER -